Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device-Reference-Cited by-同舟云学术

Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device

Published:2017-12-28 Issue:4 Volume:20 Page:792-800
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Consolo Filippo¹²,Sferrazza Giulia²³,Motolone Giulia²³,Contri Rachele³,Valerio Lorenzo²³,Lembo Rosalba³,Pozzi Loris⁴,Della Valle Patrizia⁴,De Bonis Michele⁵,Zangrillo Alberto¹³,Fiore Gianfranco B.²,Redaelli Alberto²,Slepian Marvin J.⁶,Pappalardo Federico¹³

Affiliation:

1. Università Vita Salute San Raffaele; Milan Italy

2. Department of Electronics; Information and Bioengineering, Politecnico di Milano; Milan Italy

3. Anesthesia and Cardiothoracic Intensive Care; San Raffaele Scientific Institute; Milan Italy

4. Coagulation Service and Thrombosis Research Unit; San Raffaele Scientific Institute; Milan Italy

5. Cardiac Surgery; San Raffaele Scientific Institute; Milan Italy

6. Department of Medicine and Biomedical Engineering, Sarver Heart Center; The University of Arizona; Tucson AZ USA

Funder

Fondazione Cariplo

Fondazione Cariplo e Regione Lombarida

National Institute of Health-National Institute of Biomedical Imaging and Bioengineering Quantum

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes;Gustafsson;Eur J Heart Fail,2017

2. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review;McIlvennan;Circ Heart Fail,2014

3. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device;Pagani;J Am Coll Cardiol,2009

4. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy;Park;Circ Heart Fail,2012

5. Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices;John;J Cardiovasc Transl Res,2009

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational investigation of outflow graft variation impact on hemocompatibility profile in LVADs;Artificial Organs;2023-11-14

2. Left ventricular assist devices promote changes in the expression levels of platelet microRNAs;Frontiers in Cardiovascular Medicine;2023-06-15

3. Antithrombotic therapy for durable left ventricular assist devices — current strategies and future directions;Indian Journal of Thoracic and Cardiovascular Surgery;2022-09-21

4. New Antithrombotic Strategies to Improve Outcomes With the HeartMate 3;ASAIO Journal;2022-08-09

5. High platelet reactivity is a predictor of left ventricular remodelling in patients with acute myocardial infarction;ESC Heart Failure;2022-07-31